Western Pacific Region (WPR)
This guideline applies to cervical squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, which accounts for more than 90% of cervical cancers. Current treatment strategies are influenced by a combination of hospital equipment, technical and patient’s condition.
The webpage provides treatment options for cervical cancer, varying by stage, fertility desires, and age. TReatment options include surgery, radiation, chemotherapy, or combinations, with precancerous abnormalities often treated with less invasive methods like loop excision or cone biopsy.
The aim of PCA’s effort is to increase access for all Australians with a life limiting condition, to a quality palliative care approach, and to assist health professionals and services to provide improved palliative care services outside of, or in consultation with, specialist palliative care services.
A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.
MDC is an integrated team approach to health care in which medical and allied health care professionals consider all relevant treatment options and collaboratively develop an individual treatment and care plan for each patient. Cancer Australia has developed web-based practical tools to assist health professionals and health service administrators implement MDC at the local level.
This clinical practice guideline is a systematic synthesis of evidence to address the management of abnormal cervical cancer screening results among adult females, which include ASCUS on cytology and positive high risk HPV DNA test.